HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis

Shuoshuo Ma,Yang Ma,Feiyu Qi,Jiasheng Lei,Fangfang Chen,Wanliang Sun,Dongdong Wang,Shuo Zhou,Zhong Liu,Zheng Lu,Dengyong Zhang
DOI: https://doi.org/10.1186/s12957-023-03176-6
2023-09-18
World Journal of Surgical Oncology
Abstract:Human hydroxysteroid dehydrogenase-like 2 (HSDL2), which regulates cancer progression, is involved in lipid metabolism. However, the role of HSDL2 in cholangiocarcinoma (CCA) and the mechanism by which it regulates CCA progression by modulating ferroptosis are unclear.
oncology,surgery
What problem does this paper attempt to address?